Clinical Trials Logo
NCT number NCT00817063
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 3
Start date January 2009
Completion date August 2012

Clinical Trial Summary

The purpose of this study is to investigate the safety and efficacy of alitretinoin in the treatment of severe chronic hand eczema that does not respond to treatment with potent topical steroids.


Clinical Trial Description

Chronic hand eczema (CHE)is a distressing disease that poses difficult problems for dermatologists. CHE leads to considerable work-absenteeism, disability and exclusion from labour market. Conventional treatments, including highly potent topical steroids, yield often unsatisfactory results. This study investigates the efficacy and safety of oral alitretinoin, a retinoid, in patients who have not responded to avoidance of causative factors, such as contact allergens and skin irritants, non-medicated skin care and highly potent topical steroids. Eligible patients are randomly assigned to receive alitretinoin or a placebo.


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Recruiting NCT01257061 - Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment Phase 3
 Completed NCT02075632 - Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream Phase 2
 Completed NCT00143819 - Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis Phase 2
 Completed NCT02002871 - Blue Light for Treating Eczema N/A
 Completed NCT01420705 - Bacille Calmette-Guérin (BCG) Vaccine and Atopy N/A
 Recruiting NCT01012453 - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema N/A
 Completed NCT00375713 - Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema Phase 3
 Recruiting NCT02286700 - Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis Phase 3
 Completed NCT01714245 - A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients N/A
 Completed NCT01020994 - Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema Phase 2
 Active, not recruiting NCT00798226 - Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood Phase 3
 Completed NCT00076375 - Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema) Phase 2
 Completed NCT01429701 - Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous Phase 3
 Completed NCT01359787 - Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) Phase 2
 Completed NCT01407510 - HPA Axis Study in Japanese Adults Phase 2
 Recruiting NCT01143012 - Group Eczema Education Visits:Impact on Patient and Family Quality of Life N/A
 Active, not recruiting NCT01142999 - Feasibility Study of Barrier Enhancement for Eczema Prevention N/A
 Completed NCT01132651 - Cooling Pillow for Atopic Dermatitis N/A
 Recruiting NCT00710489 - Potential Research Study Participant Registry N/A
 Completed NCT00519675 - Alitretinoin in the Treatment of Chronic Hand Eczema Phase 3